PRP for knee osteoarthritis: what the evidence actually shows
Autologous blood product
PRP is the most-studied injectable in the regenerative-orthopaedics aisle: nearly 1,800 indexed papers on PRP and the knee, over 1,000 involving humans, including dozens of randomised trials. The honest summary is contested moderate evidence: many trials and meta-analyses report better pain and function than hyaluronic acid or placebo for mild-to-moderate knee osteoarthritis; a few rigorous recent trials found no benefit — enough disagreement that major guidelines still call the evidence inconclusive.
PubMed footprint (2026-08-29): 1,797 indexed publications, 1,044 involving humans (search: "platelet-rich plasma" knee).
What it is
Platelet-rich plasma is made by spinning a patient’s own blood to concentrate platelets, then injecting the concentrate into the joint. Platelet granules release growth factors involved in tissue signalling — the proposed mechanism for symptom relief in osteoarthritis.
What the research actually shows
The trial base is genuinely large but heterogeneous: preparation methods, platelet counts and injection schedules differ study to study, which is why meta-analyses disagree. Patterns that hold up reasonably well: symptom improvements over 6–12 months in mild-to-moderate disease, generally outperforming hyaluronic acid injections; no evidence of cartilage regrowth; diminishing returns in advanced arthritis. Rigorous placebo-controlled trials from the 2020s split — some positive, at least one high-profile null.
PRP vs “stem cells” for knees
Clinics often sell PRP and cell injections side by side. Our registry snapshot lists 124 MSC trials for knee osteoarthritis versus this far larger published PRP literature — PRP is cheaper, simpler, and has more human outcome data today, while cell therapies remain investigational. If a clinic prices “stem cells” at ten times PRP without registry-grade outcome data, that gap is marketing, not evidence.
FAQ
Does PRP help knee osteoarthritis?
Many randomised trials and meta-analyses report moderate symptom improvement in mild-to-moderate disease; several rigorous trials disagree, so guidelines call the evidence inconclusive.
Is PRP a stem-cell therapy?
No. It is a platelet concentrate from your own blood and contains essentially no stem cells.
How long do PRP effects last?
Trials reporting benefit typically show it over 6–12 months, after which injections are often repeated.
Sources & further reading
→ Evaluating a clinic that sells this? Build a provider question list
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.